BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 32967622)

  • 1. Assessing risk of bias: a proposal for a unified framework for observational studies and randomized trials.
    Luijendijk HJ; Page MJ; Burger H; Koolman X
    BMC Med Res Methodol; 2020 Sep; 20(1):237. PubMed ID: 32967622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biases in Randomized Trials: A Conversation Between Trialists and Epidemiologists.
    Mansournia MA; Higgins JP; Sterne JA; Hernán MA
    Epidemiology; 2017 Jan; 28(1):54-59. PubMed ID: 27748683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
    Colditz GA
    Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the causal structure of information bias and confounding bias in randomized trials.
    Shahar E; Shahar DJ
    J Eval Clin Pract; 2009 Dec; 15(6):1214-6. PubMed ID: 20367730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A counterfactual approach to bias and effect modification in terms of response types.
    Suzuki E; Mitsuhashi T; Tsuda T; Yamamoto E
    BMC Med Res Methodol; 2013 Jul; 13():101. PubMed ID: 23902658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clarifying selection bias in cluster randomized trials.
    Li F; Tian Z; Bobb J; Papadogeorgou G; Li F
    Clin Trials; 2022 Feb; 19(1):33-41. PubMed ID: 34894795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using Causal Diagrams to Improve the Design and Interpretation of Medical Research.
    Etminan M; Collins GS; Mansournia MA
    Chest; 2020 Jul; 158(1S):S21-S28. PubMed ID: 32658648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA).
    Brettschneider C; Lühmann D; Raspe H
    GMS Health Technol Assess; 2011 Feb; 7():Doc01. PubMed ID: 21468289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of guidelines for good practice in decision-analytic modelling in health technology assessment.
    Philips Z; Ginnelly L; Sculpher M; Claxton K; Golder S; Riemsma R; Woolacoot N; Glanville J
    Health Technol Assess; 2004 Sep; 8(36):iii-iv, ix-xi, 1-158. PubMed ID: 15361314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between pacifier use and breast-feeding, sudden infant death syndrome, infection and dental malocclusion.
    Callaghan A; Kendall G; Lock C; Mahony A; Payne J; Verrier L
    JBI Libr Syst Rev; 2005; 3(6):1-33. PubMed ID: 27819973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Causal inference with observational data: the need for triangulation of evidence.
    Hammerton G; Munafò MR
    Psychol Med; 2021 Mar; 51(4):563-578. PubMed ID: 33682654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness of internet-based e-learning on clinician behavior and patient outcomes: a systematic review protocol.
    Sinclair P; Kable A; Levett-Jones T
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):52-64. PubMed ID: 26447007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conceptual framework and systematic review of the effects of participants' and professionals' preferences in randomised controlled trials.
    King M; Nazareth I; Lampe F; Bower P; Chandler M; Morou M; Sibbald B; Lai R
    Health Technol Assess; 2005 Sep; 9(35):1-186, iii-iv. PubMed ID: 16153352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limitations of individual causal models, causal graphs, and ignorability assumptions, as illustrated by random confounding and design unfaithfulness.
    Greenland S; Mansournia MA
    Eur J Epidemiol; 2015 Oct; 30(10):1101-10. PubMed ID: 25687168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation of the trial emulation approach in medical research: a scoping review.
    Scola G; Chis Ster A; Bean D; Pareek N; Emsley R; Landau S
    BMC Med Res Methodol; 2023 Aug; 23(1):186. PubMed ID: 37587484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
    Manchikanti L; Datta S; Smith HS; Hirsch JA
    Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using Causal Diagrams for Biomedical Research.
    Kyriacou DN; Greenland P; Mansournia MA
    Ann Emerg Med; 2023 May; 81(5):606-613. PubMed ID: 36328854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspective: Limiting Dependence on Nonrandomized Studies and Improving Randomized Trials in Human Nutrition Research: Why and How.
    Trepanowski JF; Ioannidis JPA
    Adv Nutr; 2018 Jul; 9(4):367-377. PubMed ID: 30032218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. General concepts in biostatistics and clinical epidemiology: Experimental studies with randomized clinical trial design.
    Estrada S; Arancibia M; Stojanova J; Papuzinski C
    Medwave; 2020 Apr; 20(3):e7869. PubMed ID: 32469850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.